Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer

被引:52
作者
Wright, Jason D.
Chen, Ling
Hou, June Y.
Burke, William M.
Tergas, Ana I.
Ananth, Cande V.
Neugut, Alfred I.
Hershman, Dawn L.
机构
[1] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY USA
[3] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, 630 W 168th St, New York, NY 10032 USA
[4] Columbia Univ, Sch Publ Hlth, Joseph L Mailman Sch Publ Hlth, New York, NY USA
[5] New York Presbyterian Hosp, New York, NY USA
关键词
ADJUVANT CHEMOTHERAPY; OPERATIVE MORTALITY; OUTCOMES; SURGERY; IMPACT; ORGANIZATION; ACCESS; INDEX;
D O I
10.1097/AOG.0000000000002164
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To assess whether strict adherence to quality metrics by hospitals could explain the association between hospital volume and survival for ovarian cancer. METHODS: We used the National Cancer Database to perform a retrospective cohort study of women with ovarian cancer from 2004 to 2013. Hospitals were stratified by annual case volume into quintiles (2 or less, 2.01-5, 5.01-9, 9.01-19.9, 20 cases or greater) and by adherence to ovarian cancer quality metrics into quartiles. Hospital-level adjusted 2- and 5-year survival rates were compared based on volume and adherence to the quality metrics. RESULTS: A total of 100,725 patients at 1,268 hospitals were identified. Higher volume hospitals were more likely to adhere to the quality metrics. Both 2- and 5-year survival increased with hospital volume and with adherence to the measured quality metrics. For example, 2- year survival increased from 64.4% (95% CI 62.5-66.4%) at low-volume to 77.4% (95% CI 77.0-77.8%) at high-volume centers and from 66.5% (95% CI 65.5-67.5%) at low-quality to 77.3% (95% CI 76.8-77.7%) at high-quality hospitals (P<.001 for both). For each hospital volume category, survival increased with increasing adherence to the quality metrics. For example, in the lowest volume hospitals (two or less cases annually), adjusted 2- year survival was 61.4% (95% CI 58.4-64.5%) at hospitals with the lowest adherence to quality metrics and rose to 65.8% (95% CI 61.2-70.8%) at the hospitals with highest adherence to the quality metrics (P<.001). However, lower volume hospitals with higher quality scores still had survival that was lower than higher volume hospitals. CONCLUSION: Although both hospital volume and adherence to quality metrics are associated with survival for ovarian cancer, low-volume hospitals that provide high-quality care still have survival rates that are lower than high-volume centers.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 37 条
  • [1] Time for centralizing patients with ovarian cancer: what are we waiting for?
    Aletti, Giovanni D.
    Cliby, William A.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 142 (02) : 209 - 210
  • [2] [Anonymous], 2016, Clinical Practice Guidelines in Oncology
  • [3] Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery
    Auerbach, Andrew D.
    Hilton, Joan F.
    Maselli, Judith
    Pekow, Penelope S.
    Rothberg, Michael B.
    Lindenauer, Peter K.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (10) : 696 - U6
  • [4] The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
    Bilimoria, Karl Y.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) : 683 - 690
  • [5] Surgeon volume and operative mortality in the United States
    Birkmeyer, JD
    Stukel, TA
    Siewers, AE
    Goodney, PP
    Wennberg, DE
    Lucas, FL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) : 2117 - 2127
  • [6] Hospital volume and surgical mortality in the United States.
    Birkmeyer, JD
    Siewers, AE
    Finlayson, EVA
    Stukel, TA
    Lucas, FL
    Batista, I
    Welch, HG
    Wennberg, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) : 1128 - 1137
  • [7] High-volume ovarian cancer care: Survival impact and disparities in access for advanced-stage disease
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Randall, Leslie M.
    Anton-Culver, Hoda
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 403 - 410
  • [8] Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Anton-Culver, Hoda
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (06) : 1226 - 1234
  • [9] The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Bristow, Robert E.
    Palis, Bryan E.
    Chi, Dennis S.
    Cliby, William A.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 118 (03) : 262 - 267
  • [10] Analysis of Contemporary Trends in Access to High-Volume Ovarian Cancer Surgical Care
    Bristow, Robert E.
    Puri, Isha
    Diaz-Montes, Teresa P.
    Giuntoli, Robert L.
    Armstrong, Deborah K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3422 - 3430